NCR2 and neoplasm: Expression of this molecule is typical of activated NK cells with high cytotoxic activity [52], but tumors can regulate NKp44 ligand expression to escape NK cell immune response, inducing expression by tumor ta-get cells of exosomal proliferating cell nuclear antigen (PCNA) when physically contacted by NK cells [53], thus explaining its high expression in CD56DIM and BRIGHT subsets.